[HTML][HTML] The gut microbiome in Alzheimer's disease: what we know and what remains to be explored

S Chandra, SS Sisodia, RJ Vassar - Molecular neurodegeneration, 2023 - Springer
Abstract Alzheimer's disease (AD), the most common cause of dementia, results in a
sustained decline in cognition. There are currently few effective disease modifying therapies …

[HTML][HTML] Diet in the prevention of Alzheimer's disease: current knowledge and future research requirements

O Stefaniak, M Dobrzyńska, S Drzymała-Czyż… - Nutrients, 2022 - mdpi.com
Alzheimer's disease is a progressive brain disease that is becoming a major health problem
in today's world due to the aging population. Despite it being widely known that diet has a …

Effect of ultra-processed diet on gut microbiota and thus its role in neurodegenerative diseases

EEM Leo, MRS Campos - Nutrition, 2020 - Elsevier
The current dietary pattern is characterized by high consumption of ultra-processed foods
and lower consumption of fiber and vegetables, environmental factors that are associated …

[HTML][HTML] High-fat diet exacerbates cognitive decline in mouse models of Alzheimer's disease and mixed dementia in a sex-dependent manner

OJ Gannon, LS Robison, AE Salinero… - Journal of …, 2022 - Springer
Abstract Background Approximately 70% of Alzheimer's disease (AD) patients have co-
morbid vascular contributions to cognitive impairment and dementia (VCID); this highly …

[HTML][HTML] High fat diet worsens Alzheimer's disease-related behavioral abnormalities and neuropathology in APP/PS1 mice, but not by synergistically decreasing …

O Bracko, LK Vinarcsik, JC Cruz Hernández… - Scientific reports, 2020 - nature.com
Obesity is linked to increased risk for and severity of Alzheimer's disease (AD). Cerebral
blood flow (CBF) reductions are an early feature of AD and are also linked to obesity. We …

[HTML][HTML] The effect of dietary fat consumption on Alzheimer's disease pathogenesis in mouse models

A Amelianchik, L Sweetland-Martin… - Translational Psychiatry, 2022 - nature.com
Alzheimer's disease (AD) is a fatal cognitive disorder with proteinaceous brain deposits,
neuroinflammation, cerebrovascular dysfunction, and extensive neuronal loss over time. AD …

A comprehensive review on the prevention and regulation of Alzheimer's disease by tea and its active ingredients

Y Huang, Y Wei, J Xu, X Wei - Critical Reviews in Food Science …, 2023 - Taylor & Francis
Alzheimer's disease (AD) has brought a heavy burden to society as a representative
neurodegenerative disease. The etiology of AD combines multiple factors, concluding …

Early or late gestational exposure to maternal immune activation alters neurodevelopmental trajectories in mice: an integrated neuroimaging, behavioral, and …

E Guma, P do Couto Bordignon, GA Devenyi… - Biological …, 2021 - Elsevier
Background Exposure to maternal immune activation (MIA) in utero is a risk factor for
neurodevelopmental disorders later in life. The impact of the gestational timing of MIA …

[HTML][HTML] Liraglutide Protects Against Brain Amyloid-β1–42 Accumulation in Female Mice with Early Alzheimer's Disease-Like Pathology by Partially Rescuing …

AI Duarte, E Candeias, IN Alves, D Mena… - International journal of …, 2020 - mdpi.com
Alzheimer's disease (AD) is the most common form of dementia worldwide, being
characterized by the deposition of senile plaques, neurofibrillary tangles (enriched in the …

[HTML][HTML] Stress-inducible phosphoprotein 1 (HOP/STI1/STIP1) regulates the accumulation and toxicity of α-synuclein in vivo

RE Lackie, AS de Miranda, MP Lim, V Novikov… - Acta …, 2022 - Springer
The predominantly pre-synaptic intrinsically disordered protein α-synuclein is prone to
misfolding and aggregation in synucleinopathies, such as Parkinson's disease (PD) and …